Dual immunofluorescence study of citrullinated proteins in Parkinson diseased substantia nigra

Neuroscience Letters

Volumn 495, Issue 1, 2011, Pages 26-29

  Nicholas, Anthony P ^a  

^a The University of Alabama at Birmingham   (United States)

Author keywords

Astrocytes; Citrulline; Deimination; Dopamine; Glial fibrillary acidic protein; Tyrosine hydroxylase

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; TYROSINE 3 MONOOXYGENASE;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; ASTROCYTES; CASE-CONTROL STUDIES; CITRULLINE; DOPAMINE; FLUORESCENT ANTIBODY TECHNIQUE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; NERVE TISSUE PROTEINS; NEURONS; PARKINSON DISEASE; PROTEIN PROCESSING, POST-TRANSLATIONAL; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 79955025436     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.03.028     Document Type: Article

References (34)

1. Akiyama K., Inoue K., Senshu T. Immunocytochemical demonstration of skeletal muscle type peptidylarginine deiminase in various rat tissues. Cell Biol. Int. Rep. 1990, 14:267-273.
2. Alvord E.C.J. The pathology of Parkinsonism. Pathology of the Nervous System 1968, Vol. 1:1152-1161. McGraw-Hill, New York.
3. Asaga H., Ishigami A. Protein deimination in the rat brain after kainate administration: citrulline-containing proteins as a novel marker of neurodegeneration. Neurosci. Lett. 2001, 299:5-8.
4. Asaga H., Ishigami A. Protein deimination in the rat brain: generation of citrulline-containing proteins in cerebrum perfused with oxygen-deprived media. Biomed. Res. 2000, 21:197-205.
5. Asaga H., Senshu T. Combined biochemical and immunocytochemical analyses of postmortem protein deimination in the rat spinal cord. Cell Biol. Int. 1993, 17:525-532.
6. Bhattacharya S.K. Retinal deimination in aging and disease. IUBMB Life 2009, 61:504-509.
7. Bhattacharya S.K., Crabb J.S., Bonilha V.L., Gu X., Takahara H., Crabb J.W. Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis. Invest. Ophthalmol. Vis. Sci. 2006, 47:2508-2514.
8. Cuthbert G.L., Daujat S., Snowden A.W., Erdjument-Bromage H., Hagiwara T., Yamada M., Schneider R., Gregory P.D., Tempst P., Bannister A.J., Kouzarides T. Histone deimination antagonizes arginine methylation. Cell 2004, 118:545-553.
9. Damier P., Hirsch E.C., Zhang P., Agid Y., Javoy-Agid F. Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience 1993, 52:1-6.
10. Forno L.S Pathology of Parkinsonism. J. Neurosurg. 1966, 24(Suppl. 2):266-271.
11. Forno L.S., DeLanney L.E., Irwin I., Di Monte D., Langston J.W. Astrocytes and Parkinson's disease. Prog. Brain Res. 1992, 94:429-436.
12. Grant J.E., Hu J., Liu T., Jain M.R., Elkabes S., Li H. Post-translational modifications in the rat lumbar spinal cord in experimental autoimmune encephalomyelitis. J. Proteome Res. 2007, 6:2786-2791.
13. Ishigami A., Ohsawa T., Hiratsuka M., Taguchi H., Kobayashi S., Saito Y., Murayama S., Asaga H., Toda T., Kimura N., Maruyama N. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J. Neurosci. Res. 2005, 80:120-128.
14. Jang B., Jin J.K., Jeon Y.C., Cho H.J., Ishigami A., Choi K.C., Carp R.I., Maruyama N., Kim Y.S., Choi E.K. Involvement of peptidylarginine deiminase-mediated post-translational citrullination in pathogenesis of sporadic Creutzfeldt-Jakob disease. Acta Neuropathol. 2010, 119:199-210.
15. Jang B., Kim E., Choi J.K., Jin J.K., Kim J.I., Ishigami A., Maruyama N., Carp R.I., Kim Y.S., Choi E.K. Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis. Am. J. Pathol. 2008, 173:1129-1142.
16. Keilhoff G., Prell T., Langnaese K., Mawrin C., Simon M., Fansa H., Nicholas A.P. Expression pattern of peptidylarginine deiminase in rat and human Schwann cells. Dev. Neurobiol. 2008, 68:101-114.
17. Mastronardi F.G., Wood D.D., Mei J., Raijmakers R., Tseveleki V., Dosch H.-M., Probert L., Casaccia-Bonnefil P., Moscarello M.A. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation. J. Neurosci. 2006, 26:11387-11396.
18. Mirza B., Hadberg H., Thomsen P., Moos T. The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease. Neuroscience 2000, 95:425-432.
19. Moscarello M.A., Pritzker L., Mastronardi F.G., Wood D.D. Peptidylarginine deiminase: a candidate factor in demyelinating disease. J. Neurochem. 2002, 81:335-343.
20. Moscarello M.A., Wood D.D., Ackerly C., Boulias C. Myelin in multiple sclerosis is developmentally immature. J. Clin. Invest. 1994, 94:146-154.
21. A.P. Nicholas, Deiminated proteins in Alzheimer's disease include beta amyloid. Neuroscience Meeting Planner, Chicago, IL, Vol. Program No. 627.7.2009, Society for Neuroscience, Online, 2009.
22. Nicholas A.P., King J.L., Sambandam T., Echols J.D., Gupta K.B., McInnis C., Whitaker J.N. Immunohistochemical localization of citrullinated proteins in adult rat brain. J. Comp. Neurol. 2003, 459:251-266.
23. Nicholas A.P., Sambandam T., Echols J.D., Barnum S.R. Expression of citrullinated proteins in murine experimental autoimmune encephalomyelitis. J. Comp. Neurol. 2005, 486:254-266.
24. Nicholas A.P., Sambandam T., Echols J.D., Tourtellotte W.W. Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis. J. Comp. Neurol. 2004, 473:128-136.
25. Nicholas A.P., Whitaker J.N. Preparation of a monoclonal antibody to citrullinated epitopes: its characterization and some applications to immunohistochemistry in human brain. Glia 2002, 37:328-336.
26. Raijmakers R., Vogelzangs J., Croxford J.L., Wesseling P., van Venrooij W.J., Pruijn G.J. Citrullination of central nervous system proteins during the development of experimental autoimmune encephalomyelitis. J. Comp. Neurol. 2005, 486:243-253.
27. Sambandam T., Belousova M., Accavitti-Loper M.A., Blanquicett C., Guercello V., Raijmakers R., Nicholas A.P. Increased peptidylarginine deiminase type II in hypoxic astrocytes. Biochem. Biophys. Res. Commun. 2004, 325:1324-1329.
28. Shimada N., Handa S., Uchida Y., Fukuda M., Maruyama N., Asaga H., Choi E.K., Lee J., Ishigami A. Developmental and age-related changes of peptidylarginine deiminase 2 in the mouse brain. J. Neurosci. Res. 2010, 88:798-806.
29. Teismann P., Schulz J.B. Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation. Cell Tissue Res. 2004, 318:149-161.
30. Vila M., Jackson-Lewis V., Guégan C., Wu D.C., Teismann P., Choi D.K., Tieu K., Przedborski S. The role of glial cells in Parkinson's disease. Curr. Opin. Neurol. 2001, 14:483-489.
31. Vincent S.R., Leung E., Watanabe K. Immunohistochemical localization of peptidylarginine deiminase in rat brain. J. Chem. Neuroanat. 1992, 5:159-168.
32. Vossenaar E.R., Zendman A.J.W., van Venrooij W.J., Pruijn G.J.M. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003, 25:1106-1118.
33. Wakabayashi K., Hayashi S., Yoshimoto M., Kudo H. NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol. 2000, 99:14-20. T.H.
34. Wood D.D., Bilbao J.M., O'Connors P., Moscarello M.A. Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann. Neurol. 1996, 40:18-24.